Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2001-07-03
2002-08-06
Azpuru, Carlos (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S502000, C264S004100, C264S004330, C264S004600, C428S402210
Reexamination Certificate
active
06428815
ABSTRACT:
BACKGROUND OF THE INVENTION
It is known in the pharmaceutical industry that the rate of dissolution of a particulate drug can increase with specific surface area (e.g., decreasing particle size). This increase can result in enhanced bioavailability of the particulate drug. In sustained release compositions in which a drug is dispersed within a matrix, for example, a polymer matrix, improvements in release profiles are typically seen as a result of reduction in the particle size of the dispersed drug. In particular, particle size reduction can reduce the initial release or burst often associated with sustained release compositions. Therefore, it is often desirable to minimize and control the particle size of a drug.
SUMMARY OF THE INVENTION
The present invention relates to submicron particles of a biologically active agent and a method of preparing the submicron particles. The invention further relates to sustained release compositions comprising the submicron particles of biologically active agent described herein and to a method of preparing and administering the sustained release composition.
The method for preparing submicron particles of a biologically active agent comprises the steps of atomizing using multifluid atomization a dispersed system comprising at least one biologically active agent and at least one solvent at a mass flow ratio of about 0.30 or greater to produce droplets, freezing the droplets to produce frozen droplets, removing the solvent from the frozen droplets to produce friable microstructures, forming a dispersion of the friable microstructures in at least one non-solvent for the biologically active agent and fragmenting the dispersed friable microstructures to produce submicron particles of the biologically active agent.
The submicron particles of a biologically active agent, as described herein, are prepared according to the method of the invention. The submicron particles of a biologically active agent are prepared by atomizing using multifluid atomization a dispersed system comprising at least one biologically active agent and at least one solvent at a mass flow ratio of about 0.30 or greater to produce droplets, freezing the droplets to produce frozen droplets, removing the solvent from the frozen droplets to produce friable microstructures, forming a dispersion of the friable microstructures in at least one non-solvent for the biologically active agent and fragmenting the dispersed friable microstructures to produce submicron particles of the biologically active agent.
The method of the invention for producing a composition for the sustained release of a biologically active agent comprises the steps of atomizing using multifluid atomization a dispersed system comprising at least one biologically active agent and at least one solvent at a mass flow ratio of about 0.30 or greater to produce droplets, freezing the droplets to produce frozen droplets, removing the solvent from the frozen droplets to produce friable microstructures, forming a dispersion of the friable microstructures in at least one non-solvent for the biologically active agent, fragmenting the dispersed friable microstructures to produce submicron particles of the biologically active agent, providing a suspension comprising the submicron particles of the biologically active agent, at least one biocompatible polymer and at least one polymer solvent and removing the polymer solvent to form a solid polymer/active agent matrix.
The composition for sustained release of a biologically active agent is likewise prepared according to the method of the invention. In other words, the composition for the sustained release of a biologically active agent as described herein is a composition prepared by the method comprising the steps of atomizing using multifluid atomization a dispersed system comprising at least one biologically active agent and at least one solvent at a mass flow ratio of about 0.30 or greater to produce droplets, freezing the droplets to produce frozen droplets, removing the solvent from the frozen droplets to produce friable microstructures, forming a dispersion of the friable microstructures in at least one non-solvent for the biologically active agent, fragmenting the dispersed friable microstructures to form submicron particles of the biologically active agent, providing a suspension comprising the submicron particles of biologically active agent, at least one biocompatible polymer, and at least one polymer solvent, and removing the polymer solvent to form a solid polymer/active agent matrix.
The sustained release composition of the present invention can be used in a method for providing a therapeutically, prophylactically, or diagnostically effective amount of a biologically active agent to a subject for a sustained period. The invention therefore also relates to a method for providing a therapeutically, prophylactically or diagnostically effective amount of a biologically active agent to a subject for a sustained period, comprising administering a dose of the sustained release composition prepared as described herein to a subject over a therapeutically useful period of time.
The invention has numerous advantages. For example, the submicron particles retain biological activity and are prepared with minimal agglomeration or aggregation. In addition, the submicron particles of biologically active agent, once formed, can, without isolation or additional comminution steps, be processed to form a composition for sustained release of the biologically active agent. The sustained release compositions, which are prepared according to the claimed method, exhibit a more favorable release profile than that observed with compositions having larger particles of biologically active agent incorporated therein. For example, the sustained release compositions having submicron particles show a decrease in the release of agent over the first twenty-four hours, and/or show an increase in the duration of sustained release, thereby possibly providing increased therapeutic benefits.
REFERENCES:
patent: 3313032 (1967-04-01), Malecki
patent: 3620776 (1971-11-01), Mishkin et al.
patent: 3928566 (1975-12-01), Briggs et al.
patent: 4073158 (1978-02-01), Guiller
patent: 4323478 (1982-04-01), Adams et al.
patent: 4329787 (1982-05-01), Newton
patent: 4479363 (1984-10-01), Gibson et al.
patent: 4704873 (1987-11-01), Imaike et al.
patent: 4748817 (1988-06-01), Oura et al.
patent: 4843840 (1989-07-01), Gibson
patent: 4848094 (1989-07-01), Davis et al.
patent: 5307640 (1994-05-01), Fawzy et al.
patent: 5475984 (1995-12-01), Fermani et al.
patent: 5654010 (1997-08-01), Johnson et al.
patent: 5656297 (1997-08-01), Bernstein et al.
patent: 5674534 (1997-10-01), Zale et al.
patent: 5711968 (1998-01-01), Tracy et al.
patent: 5727333 (1998-03-01), Folan
patent: 5817343 (1998-10-01), Burke
patent: 5911851 (1999-06-01), Bartels et al.
patent: 5912015 (1999-06-01), Bernstein et al.
patent: 5922253 (1999-07-01), Herbert et al.
patent: 6284283 (2001-09-01), Costantino et al.
patent: 0 478 118 (1991-07-01), None
patent: WO 90/13285 (1990-11-01), None
patent: WO 93/17668 (1993-09-01), None
patent: WO 93/25221 (1993-12-01), None
patent: WO 95/29664 (1995-11-01), None
patent: WO 96/40074 (1996-12-01), None
Beganski Christopher P.
Costantino Henry R.
Jaworowicz Warren E.
Tracy Mark A.
Alkermes Controlled Therapeutics Inc.
Azpuru Carlos
LandOfFree
Method of producing sub-micron particles of biologically... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of producing sub-micron particles of biologically..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing sub-micron particles of biologically... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2879185